New products soon?































The CEO will lie through his teeth in order to create the false impression that performance has improved. Raise drug prices in the short term, and Revenues go up. How is this improved performance through hard work? The CEO is looking for the biggest bang in the short term. This company is not headed in the right direction. It's headed for a junkyard sale.
 






get it through your head.

when they say pharmaceuticals and 1 Billion, they are not talking about the Branded RX drug line. T

They area talking about generics and they are talking about OCT products. All the stuff they had to throw into the pharmaceutical basket to get pharma companies to look at the pharma company.

Branded rx makes 100 mil give or take.
Pharmaceuticals doing 1 Billion is Generics and OCT.

B&L does one thing well. It makes contact lens solution and they have a huge international market share. Retail pharmacy. Contact lens reps drive that.

Pharma reps drive company cars and little else.
They barely maintain the business they have.
But if you have a 100 million dollar revenue stream, it's a no brainer to hire a pharma rep and pay them about 100K to maintain a 1 million dollar territory.
Got the math. No end game there folks. no career. Job for the short term.
 






$1 billion is US Rx branded, US Rx generic, vitamins, Alaway, Opcon, France, Freda, Germany, Italy and all the other bits and pieces. You are right: having 100 reps generating $100 million with high margins and price increased growth @ $100k per year is fantastic business. It allows senior managers to draw big salaries on the back of the reps. I see Occupy Tampa comin'.
 






Is there anyway to accelerate the timelines for these new products? The CEO says he changed the name R&D to D&R to emphasize that he is focused on Development but where are the products?

My guess is that there still is 90% of everyone is doing research and pretending they are doing development. The other 10% that are just doing Development are getting rolled over the coals every day because there just in not enough Development people working on the projects.

Time to do a serious reorg to make sure people get focused on Development.
 






Is there anyway to accelerate the timelines for these new products? The CEO says he changed the name R&D to D&R to emphasize that he is focused on Development but where are the products?

My guess is that there still is 90% of everyone is doing research and pretending they are doing development. The other 10% that are just doing Development are getting rolled over the coals every day because there just in not enough Development people working on the projects.

Time to do a serious reorg to make sure people get focused on Development.

New products or D&R may not matter anymore. For the IPO or sale of the company "potential" new products may be good enough. Actually getting an FDA approval may hurt the IPO or sale as "potential" looks much better than reality. If B+L shows the real sales instead of projected sales IPO value or sale of the company could suffer.

The company will keep D&R in a holding pattern as a "for show" talking point in negotiations. If you are in D&R just sit on your hands for a few years until the sale or IPO. You will not be able to develop anything until then.
 






New products or D&R may not matter anymore. For the IPO or sale of the company "potential" new products may be good enough. Actually getting an FDA approval may hurt the IPO or sale as "potential" looks much better than reality. If B+L shows the real sales instead of projected sales IPO value or sale of the company could suffer.

The company will keep D&R in a holding pattern as a "for show" talking point in negotiations. If you are in D&R just sit on your hands for a few years until the sale or IPO. You will not be able to develop anything until then.

That's what they have been doing for years (like many in management): sitting on their hands